Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Statistics

Total Valuation

TVTX has a market cap or net worth of $1.41 billion. The enterprise value is $1.54 billion.

Market Cap	1.41B
Enterprise Value	1.54B

Important Dates

The last earnings date was Thursday, October 31, 2024, before market open.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	n/a

Share Statistics

TVTX has 78.05 million shares outstanding. The number of shares has increased by 8.47% in one year.

Shares Outstanding	78.05M
Shares Change (YoY)	+8.47%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	1.06%
Owned by Institutions (%)	89.56%
Float	57.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.87
Forward PS	5.60
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	7.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.71

Current Ratio	1.71
Quick Ratio	1.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-25.00

Financial Efficiency

Return on equity (ROE) is -279.94% and return on invested capital (ROIC) is -33.07%.

Return on Equity (ROE)	-279.94%
Return on Assets (ROA)	-26.14%
Return on Capital (ROIC)	-33.07%
Revenue Per Employee	$535,387
Profits Per Employee	-$924,879
Employee Count	380
Asset Turnover	0.30
Inventory Turnover	16.58

Taxes

In the past 12 months, TVTX has paid $260,000 in taxes.

Income Tax	260,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +159.68% in the last 52 weeks. The beta is 0.70, so TVTX's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+159.68%
50-Day Moving Average	14.70
200-Day Moving Average	9.55
Relative Strength Index (RSI)	63.26
Average Volume (20 Days)	1,882,859

Short Selling Information

The latest short interest is 8.11 million, so 10.39% of the outstanding shares have been sold short.

Short Interest	8.11M
Short Previous Month	6.96M
Short % of Shares Out	10.39%
Short % of Float	14.01%
Short Ratio (days to cover)	3.02

Income Statement

In the last 12 months, TVTX had revenue of $203.45 million and -$351.45 million in losses. Loss per share was -$4.55.

Revenue	203.45M
Gross Profit	-21.48M
Operating Income	-279.69M
Pretax Income	-145.55M
Net Income	-351.45M
EBITDA	-238.74M
EBIT	-279.69M
Loss Per Share	-$4.55

Balance Sheet

The company has $277.44 million in cash and $402.43 million in debt, giving a net cash position of -$125.00 million or -$1.60 per share.

Cash & Cash Equivalents	277.44M
Total Debt	402.43M
Net Cash	-125.00M
Net Cash Per Share	-$1.60
Equity (Book Value)	-30.45M
Book Value Per Share	-0.39
Working Capital	134.70M

Cash Flow

In the last 12 months, operating cash flow was -$272.23 million and capital expenditures -$107,000, giving a free cash flow of -$272.34 million.

Operating Cash Flow	-272.23M
Capital Expenditures	-107,000
Free Cash Flow	-272.34M
FCF Per Share	-$3.49

Margins

Gross margin is -10.56%, with operating and profit margins of -137.48% and -172.75%.

Gross Margin	-10.56%
Operating Margin	-137.48%
Pretax Margin	-171.40%
Profit Margin	-172.75%
EBITDA Margin	-117.35%
EBIT Margin	-137.48%
FCF Margin	-179.24%

Dividends & Yields

TVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.47%
Shareholder Yield	-8.47%
Earnings Yield	-24.88%
FCF Yield	-19.28%

Analyst Forecast

The average price target for TVTX is $22.69, which is 25.36% higher than the current price. The consensus rating is "Buy".

Price Target	$22.69
Price Target Difference	25.36%
Analyst Consensus	Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	33.57%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TVTX has an Altman Z-Score of -4.26 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.26
Piotroski F-Score	4